WO2000049040A3 - Antimicrobial/endotoxin neutralizing polypeptide - Google Patents
Antimicrobial/endotoxin neutralizing polypeptide Download PDFInfo
- Publication number
- WO2000049040A3 WO2000049040A3 PCT/IB2000/000271 IB0000271W WO0049040A3 WO 2000049040 A3 WO2000049040 A3 WO 2000049040A3 IB 0000271 W IB0000271 W IB 0000271W WO 0049040 A3 WO0049040 A3 WO 0049040A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- kda
- present
- endotoxin
- patient
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002362153A CA2362153C (en) | 1999-02-05 | 2000-01-27 | Antimicrobial/endotoxin neutralizing polypeptide |
DK00906569T DK1151009T3 (en) | 1999-02-05 | 2000-01-27 | Antimicrobial / endotoxin neutralizing polypeptide |
EP00906569A EP1151009B1 (en) | 1999-02-05 | 2000-01-27 | Antimicrobial/endotoxin neutralizing polypeptide |
DE60036456T DE60036456T2 (en) | 1999-02-05 | 2000-01-27 | ANTIMICROBIAL EFFECTIVE OR ENDOTOXIN NEUTRALIZING POLYPEPTIDE |
JP2000599777A JP2002541066A (en) | 1999-02-05 | 2000-01-27 | Antimicrobial / Endotoxin neutralizing polypeptide |
MXPA01007956A MXPA01007956A (en) | 1999-02-05 | 2000-01-27 | Antimicrobial/endotoxin neutralizing polypeptide. |
AU28226/00A AU758150B2 (en) | 1999-02-05 | 2000-01-27 | Antimicrobial/endotoxin neutralizing polypeptide |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/245,527 | 1999-02-05 | ||
US09/245,527 US6399570B1 (en) | 1999-02-05 | 1999-02-05 | Antimicrobial/endotoxin neutralizing polypeptide |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000049040A2 WO2000049040A2 (en) | 2000-08-24 |
WO2000049040A3 true WO2000049040A3 (en) | 2000-12-14 |
Family
ID=22927039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2000/000271 WO2000049040A2 (en) | 1999-02-05 | 2000-01-27 | Antimicrobial/endotoxin neutralizing polypeptide |
Country Status (12)
Country | Link |
---|---|
US (2) | US6399570B1 (en) |
EP (1) | EP1151009B1 (en) |
JP (1) | JP2002541066A (en) |
CN (1) | CN1362969A (en) |
AT (1) | ATE373679T1 (en) |
AU (1) | AU758150B2 (en) |
CA (1) | CA2362153C (en) |
DE (1) | DE60036456T2 (en) |
DK (1) | DK1151009T3 (en) |
ES (1) | ES2293892T3 (en) |
MX (1) | MXPA01007956A (en) |
WO (1) | WO2000049040A2 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL94183A (en) * | 1989-05-05 | 2003-09-17 | Baylor College Medicine | cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE |
US6399570B1 (en) | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
US7060677B1 (en) | 1999-11-11 | 2006-06-13 | Am-Pharma B.V. | Antimicrobial activity of the first cationic cluster of human lactoferrin |
WO2003099323A1 (en) * | 2002-05-10 | 2003-12-04 | Agennix Incorporated | Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
US7238661B2 (en) * | 2002-05-24 | 2007-07-03 | Agennix, Inc. | Oral lactoferrin in the treatment of respiratory disorders |
CA2499014A1 (en) * | 2002-09-16 | 2004-03-25 | Agennix Incorporated | Lactoferrin compositions and methods of wound treatment |
US20040152624A1 (en) * | 2002-12-06 | 2004-08-05 | Atul Varadhachary | Oral lactoferrin in the treatment of sepsis |
US7592306B2 (en) * | 2002-12-10 | 2009-09-22 | Agennix, Inc. | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
US7034126B2 (en) | 2003-05-14 | 2006-04-25 | Agennix, Inc. | Lactoferrin in the treatment of diabetes mellitus |
JP2007524654A (en) * | 2003-06-06 | 2007-08-30 | エイジェニックス インコーポレイテッド | Lactoferrin as an adjuvant in cancer vaccines |
WO2005018542A2 (en) * | 2003-07-10 | 2005-03-03 | Agennix Incorporated | Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects |
WO2005085287A1 (en) * | 2004-03-03 | 2005-09-15 | En-N-Tech, Inc. | Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions |
WO2006047744A2 (en) * | 2004-10-26 | 2006-05-04 | Agennix Incorporated | Compositions of lactoferrin related peptides and uses thereof |
AU2006332193B2 (en) | 2005-12-30 | 2012-06-28 | Evonik Operations Gmbh | Lactoferrin peptides useful as cell-penetrating peptides |
EP2050461A1 (en) | 2007-10-19 | 2009-04-22 | PharmaSurgics in Sweden AB | Peptides based on the sequence of human lactoferrin and their use |
EP2060586A1 (en) * | 2007-11-14 | 2009-05-20 | PharmaSurgics in Sweden AB | New synthetic arginine substituted peptides and their use |
US20090209486A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | Compositions of carbohydrates as dietary supplements |
US20090208588A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | GERD carbohydrate compositions |
US20090209488A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | Compositions for the treatment of exercise induced asthma |
US20090209487A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | Compositions of carbohydrates as dietary supplements |
US20090209489A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | Compositions for the treatment of diabetis, system PH disorders, high blood pressure, and a cancer marker system |
CN101294188B (en) * | 2008-06-20 | 2011-06-15 | 江南大学 | Lactoferrin antimicrobial peptide, preparing method and uses thereof |
JP5177901B2 (en) * | 2009-12-02 | 2013-04-10 | 株式会社明治 | Nutritional composition |
CN101798337B (en) * | 2010-01-29 | 2013-04-24 | 中国人民解放军第三军医大学第一附属医院 | Mutant of endotoxin neutralizing peptide and application thereof |
EP2481751A1 (en) | 2011-01-26 | 2012-08-01 | PharmaSurgics in Sweden AB | Human lactoferrin derived peptides |
JP5763024B2 (en) * | 2012-09-07 | 2015-08-12 | 株式会社明治 | Nutritional composition |
CN105101796B (en) * | 2013-02-06 | 2017-06-06 | 中央研究院 | Antibacterial victory peptide derived from hepatitis B virus nucleoprotein arginine compact district |
CN106794218A (en) * | 2014-10-08 | 2017-05-31 | 学校法人庆应义塾 | The extracellular trap baiting net of leucocyte forms inhibitor |
EP3215614B1 (en) | 2014-11-03 | 2019-05-29 | Merck Patent GmbH | Soluble intein fusion proteins and methods for purifying biomolecules |
SG11201809928VA (en) * | 2016-05-27 | 2018-12-28 | Chiaho Shih | Modified antimicrobial peptide derived from an arginine-rich domain |
CN105999236A (en) * | 2016-07-06 | 2016-10-12 | 方雅悯 | Medicament for treating bovine mastitis and application thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991013629A1 (en) * | 1990-03-14 | 1991-09-19 | Dietrich Nitsche | Use of lactoferrin to counter the toxic effects of endotoxins |
JPH0769915A (en) * | 1993-09-02 | 1995-03-14 | Snow Brand Milk Prod Co Ltd | Viral infection/proliferation inhibitor |
WO1995019372A1 (en) * | 1994-01-14 | 1995-07-20 | Xoma Corporation | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
WO1996006860A2 (en) * | 1994-08-31 | 1996-03-07 | Pharma Key B.V. | Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
JPH0873499A (en) * | 1994-09-01 | 1996-03-19 | Snow Brand Milk Prod Co Ltd | New peptide and immunopotentiator |
JPH08165248A (en) * | 1994-12-15 | 1996-06-25 | Nobuo Kuriiwa | Endotoxin-derived inflammation inhibitor |
WO1999014231A2 (en) * | 1997-09-16 | 1999-03-25 | Forssmann Wolf Georg | Bifidus stimulating peptides and its uses |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4977137B1 (en) | 1987-06-03 | 1994-06-28 | Baylor College Medicine | Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract |
US6020015A (en) * | 1988-09-22 | 2000-02-01 | Gaull; Gerald E. | Infant formula compositions and nutrition containing genetically engineered human milk proteins |
JP2805490B2 (en) * | 1989-02-07 | 1998-09-30 | 雪印乳業株式会社 | Bacterial toxin neutralizer |
US5141743A (en) * | 1989-04-27 | 1992-08-25 | University Technologies International, Inc. | Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same |
US5571691A (en) * | 1989-05-05 | 1996-11-05 | Baylor College Of Medicine | Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms |
IL94183A (en) | 1989-05-05 | 2003-09-17 | Baylor College Medicine | cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE |
US5766939A (en) | 1989-05-05 | 1998-06-16 | Baylor College Of Medicine | Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms |
US6100054A (en) | 1989-05-05 | 2000-08-08 | Baylor College Of Medicine | Production for recombinant lactoferrin and lactoferrin polypeptides using DNA sequences in various organisms |
US5849881A (en) * | 1989-05-05 | 1998-12-15 | Baylor College Medicine | Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
US5571697A (en) | 1989-05-05 | 1996-11-05 | Baylor College Of Medicine Texas Medical Center | Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus |
US5198419A (en) * | 1989-12-08 | 1993-03-30 | Immuno Japan Inc. | Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria |
EP0536805B1 (en) | 1990-01-23 | 1995-03-15 | Morinaga Milk Industry Co., Ltd. | Lactoferrin hydrolyzate for use as a tyrosinase inhibition agent |
US6066469A (en) * | 1990-03-08 | 2000-05-23 | Ferro Dynamics, Inc. | Cloning, expression, and uses of human lactoferrin |
US5240909B1 (en) * | 1990-03-14 | 1998-01-20 | Dietrich Nitsche | Use of lactoferrin for treatment of toxic effects of endotoxins |
JP2818056B2 (en) | 1990-09-07 | 1998-10-30 | 森永乳業株式会社 | Antimicrobial peptides and antimicrobial agents |
ATE148631T1 (en) * | 1990-11-13 | 1997-02-15 | Santen Pharmaceutical Co Ltd | THERAPEUTIC AGENT FOR CORNEAL INJURIES |
JP3110078B2 (en) | 1991-06-21 | 2000-11-20 | 森永乳業株式会社 | Mass production of high-purity antimicrobial peptides |
CA2128612C (en) | 1992-01-23 | 1999-06-15 | Mamoru Tomita | Antimicrobial agents and method for treating products therewith |
CA2090658A1 (en) * | 1992-03-02 | 1993-09-03 | Kunio Ando | Formulated medicine for treatment and/or prevention of opportunistic infectious diseases complicated by infection with lentivirus |
ZA932568B (en) | 1992-04-24 | 1993-11-12 | Baylor College Midecine A Non | Production of recombinant human lactoferrin |
JP3100005B2 (en) * | 1992-07-28 | 2000-10-16 | 雪印乳業株式会社 | Human immunodeficiency virus infection / growth inhibitor |
AU1809895A (en) * | 1994-02-16 | 1995-09-04 | Pharming Bv | Isolation of lactoferrin from milk |
US5531989A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
US5712247A (en) * | 1995-02-21 | 1998-01-27 | University Of North Carolina | Use of lactoferrin to modulate and/or neutralize heparin activity |
WO1996031537A1 (en) * | 1995-04-05 | 1996-10-10 | The Picower Institute For Medical Research | Agents for binding to advanced glycosylation endproducts, and methods of their use |
US20020016289A1 (en) * | 1995-06-01 | 2002-02-07 | Orla M. Conneely | Methods for treatment and prevention of helicobacter pylori infection using lactoferrin |
US5834424A (en) * | 1995-07-12 | 1998-11-10 | Gambit International Limited | Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus |
SE506529C2 (en) * | 1996-01-23 | 1997-12-22 | Semper Ab | Use of a lactoperoxidase system for the preparation of a drug against Helicobacter pylori |
US6111081A (en) * | 1996-05-31 | 2000-08-29 | Baylor College Of Medicine | Lactoferrin variants and uses thereof |
CN1228123A (en) * | 1996-08-14 | 1999-09-08 | 诺瓦提斯公司 | Peptide with inhibitory activity towards plant pathogenic fungi |
US6503881B2 (en) * | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
EP1017407A2 (en) * | 1997-02-03 | 2000-07-12 | Pharming Intellectual Property BV | Useful properties of human lactoferrin and variants thereof |
IL132293A0 (en) * | 1997-04-10 | 2001-03-19 | Agennix Inc | Use of lactoferin in the treatment of allergen induced disorders |
FR2762850B1 (en) * | 1997-05-02 | 2000-02-11 | Biocem | RECOMBINANT LACTOFERRINS, THEIR METHODS OF PRODUCTION BY PLANTS AND THEIR USES |
US20020165128A1 (en) * | 1998-04-13 | 2002-11-07 | Plaut Andrew G. | Compositions and methods for proteolytically inactivating infectious agents using lactoferrin and related molecules |
EP1074250B1 (en) * | 1998-04-30 | 2004-03-24 | Morinaga Milk Industry Co., Ltd. | Sugar coated tablets |
CA2279791C (en) * | 1998-08-14 | 2011-11-08 | Marcus B. Gohlke | Dietary supplement combining colostrum and lactorferrin in a mucosal delivery format |
GB9818938D0 (en) * | 1998-08-28 | 1998-10-21 | Alpharma As | Bioactive peptides |
US6719973B1 (en) * | 1998-12-24 | 2004-04-13 | National University Of Singapore | Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics |
US6399570B1 (en) | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
US6613741B2 (en) * | 1999-10-29 | 2003-09-02 | Ferro Dynamics, Inc. | Method for treating aseptic SIRS in humans and other animals |
TWI237695B (en) * | 1999-12-14 | 2005-08-11 | Joy Biomedical Corp | Helicobacter pylori antigens in blood |
US20040157277A1 (en) * | 2002-03-08 | 2004-08-12 | Clancy Robert Llewellyn | Methods for predicting and/or diagnosing the risk of gastric cancer |
RU2165769C1 (en) | 2000-07-13 | 2001-04-27 | Якубовская Раиса Ивановна | Antibacterial, antioxidant, immunomodulating and anticancer preparation and method of its embodiment |
US7020715B2 (en) * | 2000-08-22 | 2006-03-28 | Adaptec, Inc. | Protocol stack for linking storage area networks over an existing LAN, MAN, or WAN |
KR100454595B1 (en) * | 2001-11-30 | 2004-10-28 | 주식회사 이지바이오 시스템 | Lactoferricin gene and transformant expressing lactoferricin |
WO2003099323A1 (en) | 2002-05-10 | 2003-12-04 | Agennix Incorporated | Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
US7238661B2 (en) * | 2002-05-24 | 2007-07-03 | Agennix, Inc. | Oral lactoferrin in the treatment of respiratory disorders |
SE526038C2 (en) * | 2002-07-08 | 2005-06-21 | Gambro Lundia Ab | Polymer affinity matrix, process for its preparation and use thereof |
CA2499014A1 (en) * | 2002-09-16 | 2004-03-25 | Agennix Incorporated | Lactoferrin compositions and methods of wound treatment |
US20040152624A1 (en) * | 2002-12-06 | 2004-08-05 | Atul Varadhachary | Oral lactoferrin in the treatment of sepsis |
EP1638990B1 (en) * | 2003-06-24 | 2009-04-08 | N.V. Organon | Removal of lipopolysaccharides from protein- lipopolysaccharide complexes by nonflammable solvents |
WO2005018542A2 (en) * | 2003-07-10 | 2005-03-03 | Agennix Incorporated | Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects |
WO2006047744A2 (en) * | 2004-10-26 | 2006-05-04 | Agennix Incorporated | Compositions of lactoferrin related peptides and uses thereof |
-
1999
- 1999-02-05 US US09/245,527 patent/US6399570B1/en not_active Expired - Fee Related
-
2000
- 2000-01-27 JP JP2000599777A patent/JP2002541066A/en active Pending
- 2000-01-27 WO PCT/IB2000/000271 patent/WO2000049040A2/en active IP Right Grant
- 2000-01-27 AU AU28226/00A patent/AU758150B2/en not_active Ceased
- 2000-01-27 ES ES00906569T patent/ES2293892T3/en not_active Expired - Lifetime
- 2000-01-27 CA CA002362153A patent/CA2362153C/en not_active Expired - Fee Related
- 2000-01-27 DE DE60036456T patent/DE60036456T2/en not_active Expired - Lifetime
- 2000-01-27 CN CN00804843A patent/CN1362969A/en active Pending
- 2000-01-27 DK DK00906569T patent/DK1151009T3/en active
- 2000-01-27 EP EP00906569A patent/EP1151009B1/en not_active Expired - Lifetime
- 2000-01-27 AT AT00906569T patent/ATE373679T1/en not_active IP Right Cessation
- 2000-01-27 MX MXPA01007956A patent/MXPA01007956A/en not_active IP Right Cessation
-
2002
- 2002-05-13 US US10/145,651 patent/US7244706B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991013629A1 (en) * | 1990-03-14 | 1991-09-19 | Dietrich Nitsche | Use of lactoferrin to counter the toxic effects of endotoxins |
JPH0769915A (en) * | 1993-09-02 | 1995-03-14 | Snow Brand Milk Prod Co Ltd | Viral infection/proliferation inhibitor |
WO1995019372A1 (en) * | 1994-01-14 | 1995-07-20 | Xoma Corporation | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
WO1996006860A2 (en) * | 1994-08-31 | 1996-03-07 | Pharma Key B.V. | Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
JPH0873499A (en) * | 1994-09-01 | 1996-03-19 | Snow Brand Milk Prod Co Ltd | New peptide and immunopotentiator |
JPH08165248A (en) * | 1994-12-15 | 1996-06-25 | Nobuo Kuriiwa | Endotoxin-derived inflammation inhibitor |
WO1999014231A2 (en) * | 1997-09-16 | 1999-03-25 | Forssmann Wolf Georg | Bifidus stimulating peptides and its uses |
Non-Patent Citations (3)
Title |
---|
DATABASE WPI Section Ch Week 199519, Derwent World Patents Index; Class B04, AN 1995-144726, XP002145479 * |
DATABASE WPI Section Ch Week 199635, Derwent World Patents Index; Class B04, AN 1996-350155, XP002145478 * |
PATENT ABSTRACTS OF JAPAN vol. 1996, no. 07 31 July 1996 (1996-07-31) * |
Also Published As
Publication number | Publication date |
---|---|
CN1362969A (en) | 2002-08-07 |
US20030105006A1 (en) | 2003-06-05 |
CA2362153C (en) | 2009-11-24 |
DK1151009T3 (en) | 2008-01-28 |
ATE373679T1 (en) | 2007-10-15 |
DE60036456T2 (en) | 2008-06-19 |
AU758150B2 (en) | 2003-03-13 |
AU2822600A (en) | 2000-09-04 |
EP1151009A2 (en) | 2001-11-07 |
CA2362153A1 (en) | 2000-08-24 |
WO2000049040A2 (en) | 2000-08-24 |
ES2293892T3 (en) | 2008-04-01 |
US6399570B1 (en) | 2002-06-04 |
JP2002541066A (en) | 2002-12-03 |
MXPA01007956A (en) | 2004-08-19 |
EP1151009B1 (en) | 2007-09-19 |
DE60036456D1 (en) | 2007-10-31 |
US7244706B2 (en) | 2007-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000049040A3 (en) | Antimicrobial/endotoxin neutralizing polypeptide | |
Wiedow et al. | Elafin is a potent inhibitor of proteinase 3 | |
US8461113B2 (en) | Elastin digest compositions and methods utilizing same | |
WO2004099168A3 (en) | Substituted carboxylic acids | |
WO2004078777A3 (en) | Dipeptidyl-peptidase protected proteins | |
WO2001016330A3 (en) | Prevention of affections associated with porcine circovirus-2 | |
WO2004099192A3 (en) | Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b | |
WO2000054799A3 (en) | Medicament for treating diabetes | |
WO2000077216A3 (en) | Porcine circovirus vaccine in recombinant poxvirus | |
WO2003032994A3 (en) | Novel tri-substituted pyrimidines, method for production and use thereof as medicament | |
EA200600352A1 (en) | HYDROLYSATE OF KAZEIN, METHOD FOR ITS PREPARATION AND APPLICATION | |
MXPA05010937A (en) | Substituted phenylalkanoic acids. | |
EP1969003B8 (en) | Uses of a NEUROTROPHIC FACTOR PROTEIN | |
EP3548058B1 (en) | Compositions comprising peptide wkdeagkplvk | |
EP2039367A4 (en) | Prophylactic/therapeutic agent for neurodegenerative disease | |
NO20060675L (en) | Enhanced recombinant human interferon beta-lb polypeptides | |
TW200631949A (en) | Substituted carboxylic acids | |
RU2005127076A (en) | PEPTIDE TOXIN INHIBITORS, DERIVATIVES LL-37 | |
WO2003084979A3 (en) | Novel peptides and the application thereof in therapy | |
WO2006029487A3 (en) | Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis | |
US8815812B2 (en) | Synthetic arginine substituted peptides and their use | |
WO2010086867A3 (en) | Peptides, pharmaceutical compositions comprising same and uses thereof | |
US20110053833A1 (en) | Synthetic peptides and their use | |
JP6018614B2 (en) | Short-chain active peptide for angiotensin I converting enzyme inhibition and blood pressure reduction | |
JP2020508984A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 00804843.6 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2362153 Country of ref document: CA Ref document number: 2362153 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/007956 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2000 599777 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 28226/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000906569 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000906569 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 28226/00 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000906569 Country of ref document: EP |